TrialPharmacology research & perspectives2022

Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trial.

Behzad Hatami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.